Public Profile

Wuxi Biologics

Wuxi Biologics, officially known as WuXi AppTec Co., Ltd., is a leading global contract research, development, and manufacturing organisation (CDMO) headquartered in Wuxi, China. Founded in 2010, the company has rapidly expanded its operations across major regions, including the United States and Europe, establishing itself as a key player in the biopharmaceutical industry. Specialising in biologics, Wuxi Biologics offers a comprehensive range of services, from cell line development to commercial manufacturing. Their unique integrated platform streamlines the drug development process, enabling clients to bring innovative therapies to market more efficiently. With a strong commitment to quality and innovation, Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the global biopharmaceutical landscape.

DitchCarbon Score

How does Wuxi Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

60

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Wuxi Biologics's score of 60 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Let us know if this data was useful to you

Wuxi Biologics's reported carbon emissions

In 2024, Wuxi Biologics reported total greenhouse gas emissions of approximately 198,654,000 kg CO2e, comprising 38,346,000 kg CO2e from Scope 1 and 160,308,000 kg CO2e from Scope 2 emissions. Additionally, their Scope 3 emissions totalled about 39,468,000 kg CO2e, with significant contributions from employee commuting (19,176,000 kg CO2e) and fuel and energy-related activities (39,468,000 kg CO2e). The company has set ambitious mid-term goals to reduce its Scope 1 and Scope 2 greenhouse gas emission intensity by 50% by 2030, using 2020 as the baseline year. This commitment reflects their proactive approach to climate action within the pharmaceutical and biotechnology sector. Wuxi Biologics is also committed to achieving net-zero emissions across all scopes by 2050, aligning with global climate initiatives. Their ongoing efforts and targets demonstrate a strong commitment to sustainability and reducing their carbon footprint in the industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
11,042,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
74,361,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Wuxi Biologics's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Wuxi Biologics is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Wuxi Biologics is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pharmaron Beijing

CN
Research and development services (73)
Updated 9 days ago

Iqvia

US
Health and social work services (85)
Updated 4 days ago

Pharmaceutical Product Development, LLC

US
Research and development services (73)
Updated 4 months ago
DitchCarbon Score

Twist Bioscience Corporation

US
Health and social work services (85)
Updated 20 days ago

OmniAb, Inc.

US
Health and social work services (85)
Updated 23 days ago

Akums Drugs and Pharmaceuticals Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers